C. difficile
Detection of Toxigenic Clostridium difficile: Comparison of the Cell Culture Neutralization, Xpert C difficile, Xpert C difficile/Epi, and Illumigene C difficile Assays
5
Recombinant lipoprotein-based vaccine candidates against C. difficile infections
14
Multicenter Clinical Evaluation of the Portrait Toxigenic C difficile Assay for Detection of Toxigenic Clostridium difficile Strains in Clinical Stool Specimens
5
Evaluation of a New Automated Homogeneous PCR Assay, GenomEra C difficile, for Rapid Detection of Toxigenic Clostridium difficile in Fecal Specimens
5
Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C difficile PCR ribotype 027 in central China
14
Circulating antibody and memory B cell responses to C difficile toxins A and B in patients with C difficile associated diarrhoea, inflammatory bowel disease and cystic fibrosis
14
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C difficile colonization?
7
Multicenter Evaluation of the Quidel Lyra Direct C difficile Nucleic Acid Amplification Assay
5
In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile
6
Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients
8
Comparison of GenomEra C difficile and Xpert C difficile as Confirmatory Tests in a Multistep Algorithm for Diagnosis of Clostridium difficile Infection
5
Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non C difficile Associated Diarrhea from Healthy Controls
9
Rapid Molecular Characterization of Clostridium difficile and Assessment of Populations of C difficile in Stool Specimens
7
Efficacy of cleaning products for C difficile
7
Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C difficile associated disease
7
Evaluation of Copan FecalSwab as Specimen Type for Use in Xpert C difficile Assay
7
Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study
6
Analysis of proteomes released from in vitro cultured eight Clostridium difficile PCR ribotypes revealed specific expression in PCR ribotypes 027 and 176 confirming their genetic relatedness and clinical importance at the proteomic level
11
Isolation of Toxin Producing Clostridium difficile from Two Children with Oxacillin- and Dicloxacillin-Associated Diarrhea
5
Genotyping of outbreak related and sporadic isolates of Clostridium difficile belonging to serogroup C
7